Adult ADHD: A new disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In adults with ADHD, however, hyperactivity tends to be more subtle and is characterized by fidgeting (11).”
From A quantitative analysis of fidgeting in ADHD and its relation to performance and sustained attention on a cognitive task (2024) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976 · cited 2×
“mostly explained by methodological differences (Dulcan 1997), were settled by comprehensive meta-analyses that used ‘best estimated diagnoses’ to estimate the prevalence rate and found it to be 5–7%, with the combined type being the most common among affected subjects referred for clinical treatment (57%), and a male:…”
BackgroundPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Young Adult Outcome of Hyperactive Children: Adaptive Functioning in Major Life Activities
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000189134.97436.e2 · Cited by 1,027 · cited 1×
“Young adults diagnosed with ADHD are less likely to enrol in college (Barkley et al. 2006).”
BackgroundKooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928 · cited 4×
“Other complaints, such as feeling bored, unable to make decisions, procrastinating, being disorganised and distracted may constitute an expression of inattentiveness (Kooij et al. 2010).”
BackgroundInfluentialAttention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700 · cited 1×
“Employment problems have been documented due to patients’ poor job performance, lower occupational status (Mannuzza and Klein 2000), increased absence days (Secnik et al. 2005), more workplace accidents (Kessler et al. 2009) and lesser job stability (Murphy and Barkley 1996).”
BackgroundFrazier, T. W., Youngstrom, E. A., Glutting, J. J., & Watkins, M. W. (2007) · Journal of Learning Disabilities · doi:10.1177/00222194070400010401 · Cited by 700 · cited 1×
“Students with ADHD are more likely to be on academic probation, to have a lower grade point average and are less likely to graduate from college than their peers who do not have ADHD (Frazier et al. 2007; DuPaul et al. 2009).”
BackgroundSolanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
Clinical and Functional Outcome of Childhood Attention-Deficit/Hyperactivity Disorder 33 Years Later
Klein, R. G., Mannuzza, S., Olazagasti, M. A. R., Roizen, E., Hutchison, J. A., Lashua, E. C., & Castellanos, F. X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.271 · Cited by 619
Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000108984.11879.95 · Cited by 404
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough, J. J., & Barkley, R. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1948 · Cited by 388
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Biederman, J., Boellner, S. W., Childress, A., Lopez, F. A., Krishnan, S., & Zhang, Y. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.015 · Cited by 360 · cited 1×
“The onset of clinical effects is usually noticeable 2 h following LDX administration, last for up to 14 h and is comparable to the clinical effect seen with administration of MAS-XR (Biederman et al. 2007; Wigal et al. 2010).”
Backgroundde Graaf, R., Kessler, R. C., Fayyad, J., ten Have, M., Alonso, J., Angermeyer, M., Borges, G., Demyttenaere, K., Gasquet, I., de Girolamo, G., et al. (2008) · Occupational and Environmental Medicine · doi:10.1136/oem.2007.038448 · Cited by 355 · cited 1×
“Only a small minority of these workers received treatment despite the high potential of treatment to improve functionality (de Graaf et al. 2008).”
BackgroundFaraone, S. V., Biederman, J., Spencer, T., Mick, E., Murray, K., Petty, C., Adamson, J. J., & Monuteaux, M. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1720 · Cited by 329 · cited 2×
“Longitudinal follow-up studies indicated that approximately 2/3 of children diagnosed with ADHD experience as adults ADHD symptoms that impair their functionality (Faraone et al. 2006).”
BackgroundMethodADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
Habel, L. A., Cooper, W. O., Sox, C. M., Chan, K. A., Fireman, B. H., Arbogast, P. G., Cheetham, T. C., Quinn, V. P., Dublin, S., Boudreau, D. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1830 · Cited by 297 · cited 2×
“dence of a link between ADHD medication and cardiovascular risk (myocardial infarction, sudden death or stroke) (Habel et al. 2011).”
BackgroundComorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
Secnik, K., Swensen, A., & Lage, M. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523010-00008 · Cited by 247 · cited 2×
“Employment problems have been documented due to patients’ poor job performance, lower occupational status (Mannuzza and Klein 2000), increased absence days (Secnik et al. 2005), more workplace accidents (Kessler et al. 2009) and lesser job stability (Murphy and Barkley 1996).”
Background(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1147 · Cited by 228 · cited 1×
“Other drugs that have shown some efficacy are tricyclic antidepressants, venlafaxine and modafinil (Findling et al. 1996; Wilens et al. 1996; Mann and Bitsios 2009).”
BackgroundAdler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0903 · Cited by 218
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults
McCarthy, S., Asherson, P., Coghill, D., Hollis, C., Murray, M., Potts, L., Sayal, K., de Soysa, R., Taylor, E., Williams, T., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045245 · Cited by 215
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
Castells, X., Blanco-Silvente, L., & Cunill, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007813.pub3 · Cited by 209 · cited 3×
“Within the amphetamine group, mixed amphetamine salts (MAS) was the only drug that improved study retention, but was also associated with a higher adverse-events induced drop outs than placebo (Castells et al. 2011a).”
BackgroundFischer, M., Barkley, R. A., Smallish, L., & Fletcher, K. (2007) · Accident Analysis & Prevention · doi:10.1016/j.aap.2006.06.008 · Cited by 200 · cited 2×
“behaviour, more involvement in traffic accidents and greater likelihood for other types of accidents such as dog bites, burns or selfinflicted accidents (Swensen et al. 2004; Fischer et al. 2007; Rosenbloom and Wultz 2011).”
BackgroundCastells, X., Ramos-Quiroga, J. A., Rigau, D., Bosch, R., Nogueira, M., Vidal, X., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11539440-000000000-00000 · Cited by 197 · cited 3×
“Within the amphetamine group, mixed amphetamine salts (MAS) was the only drug that improved study retention, but was also associated with a higher adverse-events induced drop outs than placebo (Castells et al. 2011a).”
BackgroundGinsberg, Y., Hirvikoski, T., & Lindefors, N. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-112 · Cited by 191 · cited 4×
“Among adult male prison inmates, where ADHD prevalence was estimated to be as high as 45% and is most often combined with externalising symptoms of conduct disorder (R€ osler et al. 2004; Ginsberg et al. 2010), in-prison MPH treatment was found to be effective and overall safe both in the short term and in the long te…”
BackgroundInfluentialTaylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · cited 1×
“Evidence for its efficacy comes mostly from studies in children and adolescents (particularly when core ADHD symptoms are associated with oppositional behaviour), and is limited among adults (Taylor and Russo 2001; Sallee and Eaton 2010).”
BackgroundThe Age at Onset of Attention Deficit Hyperactivity Disorder
Kieling, C., Kieling, R. R., Rohde, L. A., Frick, P. J., Moffitt, T., Nigg, J. T., Tannock, R., & Castellanos, F. X. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060796 · Cited by 185 · cited 1×
“These changes were made mainly due to substantial evidence demonstrating no clinical differences between children diagnosed at the age of 7 versus those diagnosed later, in terms of severity, disorder course, outcome or treatment response (Kieling et al. 2010).”
BackgroundKessler, R. C., Lane, M., Stang, P. E., & Van Brunt, D. L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003309 · Cited by 183
Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0113 · Cited by 180
Adler, L. A., Liebowitz, M., Kronenberger, W., Qiao, M., Rubin, R., Hollandbeck, M., Deldar, A., Schuh, K., & Durell, T. (2009) · Depression and Anxiety · doi:10.1002/da.20549 · Cited by 176 · cited 1×
“ATX has been shown to be effective in long-term use, particularly when ADHD is combined with anxiety, emotional dysregulation or addictive potential due to co-morbid substance use disorder (Adler et al. 2009; Marchant et al. 2011; Ginsberg et al. 2012).”
BackgroundFredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173 · cited 1×
“In recent years, several long-term randomised control trials (RCT’s) have found treatment to be clearly beneficial, with statistically significant reduction in both, patients’ symptoms and clinicians estimated severity of the disorder (Fredriksen et al. 2013).”
BackgroundAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Pennick (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s9749 · Cited by 170 · cited 1×
“It differs from other extended-release stimulants in its unusual mechanism of action which acts as a pro-drug that requires enzymatic breakdown in red blood cells thus becoming the active ingredient D-amphetamine and the amino acid lysine (Pennick 2010).”
BackgroundBarkley, R. A., & Brown, T. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900014036 · Cited by 163
The psychosocial functioning of children and spouses of adults with ADHD
Minde, K., Eakin, L., Hechtman, L., Ochs, E., Bouffard, R., Greenfield, B., & Looper, K. (2003) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00150 · Cited by 156 · cited 1×
“Moreover, in such families, there is an increased risk for poorer parent-child relationships (Minde et al. 2003).”
BackgroundOccupational issues of adults with ADHD
Adamou, M., Arif, M., Asherson, P., Aw, T.-C., Bolea, B., Coghill, D., Guðjónsson, G., Halmøy, A., Hodgkins, P., Müller, U., et al. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-59 · Cited by 152
Koesters, M., Becker, T., Kilian, R., Fegert, J., & Weinmann, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108092338 · Cited by 142 · cited 1×
“A meta-analysis published by Koesters et al. (2009) reported an overall moderate effect of 0.42, with no dose-response effect.”
BackgroundInfluentialWigal, T., Brams, M., Gasior, M., Gao, J., Squires, L., Giblin, J., & 316 Study Group (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-34 · Cited by 136 · cited 1×
“The onset of clinical effects is usually noticeable 2 h following LDX administration, last for up to 14 h and is comparable to the clinical effect seen with administration of MAS-XR (Biederman et al. 2007; Wigal et al. 2010).”
BackgroundRösler, M., Retz, W., Fischer, R., Ose, C., Alm, B., Deckert, J., Philipsen, A., Herpertz, S., & Ammer, R. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003624197 · Cited by 131
Faraone, S. V., Biederman, J., Feighner, J. A., & Monuteaux, M. C. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.830 · Cited by 111 · cited 1×
“An additional burden may be the need to cope with one or more children with ADHD, since it has been shown that approximately 20% of parents of children with ADHD have themselves ADHD (Faraone et al. 2000).”
BackgroundPolanczyk, G., Caspi, A., Houts, R., Kollins, S. H., Rohde, L. A., & Moffitt, T. E. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.12.014 · Cited by 109 · cited 2×
“Furthermore, findings suggest that the majority of children who had symptoms at the age of 12 also experienced symptoms at the age of 7 (Polanczyk et al. 2010).”
BackgroundComparison of the burden of illness for adults with ADHD across seven countries: a qualitative study
Brod, M., Pohlman, B., Lasser, R., & Hodgkins, P. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-47 · Cited by 102
Weisler, R., Young, J., Mattingly, G., Gao, J., Squires, L., Adler, L., & 304 Study Group (2009) · CNS Spectrums · doi:10.1017/s1092852900024056 · Cited by 94 · cited 2×
“%) completed the follow-up study, the statistically significant improvement found in the original study was maintained throughout the follow-up period (Weisler et al. 2009).”
BackgroundResultComorbidity of ADHD and Substance Use Disorder (SUD): A Neuroimaging Perspective
Frodl, T. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710365054 · Cited by 87
Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Kotarski, M., & Spencer, T. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ee84a7 · Cited by 76
Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders
Wilson, J. J., & Levin, F. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.751 · Cited by 71
Cunill, R., Castells, X., Tobias, A., & Capellà, D. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3473 · Cited by 70
Durell, T. M., Adler, L. A., Williams, D. W., Deldar, A., McGough, J. J., Glaser, P. E., Rubin, R. L., Pigott, T. A., Sarkis, E. H., & Fox, B. K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827d8a23 · Cited by 64 · cited 1×
“Irritability, dizziness, dyspepsia and erectile dysfunction were reported significantly more often with atomoxetine than with placebo administration (Durell et al. 2014).”
BackgroundSantosh, P. J., Sattar, S., & Canagaratnam, M. (2011) · CNS Drugs · doi:10.2165/11593070-000000000-00000 · Cited by 62 · cited 1×
“Among the stimulants, MPH and amphetamines produced comparable improvements (Faraone and Glatt 2010; Santosh et al. 2011).”
BackgroundManeeton, N., Maneeton, B., Srisurapanont, M., & Martin, S. D. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02264.x · Cited by 60 · cited 1×
“In addition, it might be beneficial in cases of co-morbid depression or nicotine dependence (Maneeton et al. 2011).”
BackgroundRamos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54
Moen, M. D., & Keam, S. J. (2009) · CNS Drugs · doi:10.2165/11201140-000000000-00000 · Cited by 27
Research works printed but not linked: 44
- 10.1176/appi.books.9780890425596 · DOI · Paper page
- 10.1177/0269881114542453 · DOI · Paper page
- 10.1089/cap.2006.0098 · DOI · Paper page
- 10.1080/10349120600716182 · DOI · Paper page
- 10.1177/1087054710365982 · DOI · Paper page
- 10.1002/14651858.CD007813.pub2 · DOI · Paper page
- 10.1007/s00787-012-0360-z · DOI
- 10.1097/00004583-199710001-00007 · DOI · Paper page
- 10.1177/1087054709340650 · DOI · Paper page
- 10.1176/appi.ajp.163.10.1720 · doi:10.1176/appi.ajp.163.10.1720 · Paper page
- 10.4088/JCP.08m04902 · doi:10.4088/jcp.08m04902
- Faraone SV, 2003, World Psychiatry, 2, 104
- 10.1517/14656566.8.13.2127 · DOI
- 10.1192/bjp.bp.106.034389 · DOI · Paper page
- Findling RL, 1996, J Clin Psychiatry, 57, 184
- 10.1097/00004583-200012000-00014 · DOI · Paper page
- 10.1177/108705470200500302 · DOI · Paper page
- 10.1007/s00406-012-0317-8 · DOI · Paper page
- 10.1177/1087054711413074 · DOI · Paper page
- Van de Glind G, 2013, Int J Methods Psychiatr Res, 22, 232, 10.1002/mpr.1397 · DOI · Paper page
- Goodman DW., 2007, Psychiatry (Edgmont), 4, 39
- 10.1007/s13311-012-0127-8 · DOI · Paper page
- 10.1176/ajp.153.9.1143 · DOI · Paper page
- 10.1007/s12325-013-0085-5 · DOI
- 10.1002/brb3.78 · DOI · Paper page
- 10.1177/0269881108091258 · DOI
- Mannuzza S, 2000, Child Adolesc Psychiatr Clin N Am, 9, 711, 10.1016/S1056-4993(18)30114-7 · DOI · Paper page
- 10.1007/s12402-011-0054-2 · DOI
- 10.1016/j.euroneuro.2012.06.011 · DOI · Paper page
- 10.1176/appi.ajp.2015.14101266 · DOI · Paper page
- 10.1002/jclp.20123 · DOI · Paper page
- Polanczyk G, 2010, J Am Acad Child Adolesc Psychiatry, 49, 210
- 10.1586/ern.12.109 · DOI · Paper page
- 10.1016/j.aap.2010.08.002 · DOI
- 10.1007/s00406-004-0516-z · DOI · Paper page
- 10.1517/14656566.2010.517523 · DOI · Paper page
- 10.1007/s00406-007-0712-8 · DOI · Paper page
- 10.1016/j.biopsych.2006.07.032 · DOI
- 10.1016/S1054-139X(04)00055-2 · doi:10.1016/s1054-139x(04)00055-2 · Paper page
- 10.1517/14656560902762873 · DOI · Paper page
- 10.4088/JCP.08m04709pur · DOI · Paper page
- 10.1177/1087054709356188 · DOI · Paper page
- 10.1097/01.CHI.0000046907.27264.E4 · DOI
- Wilens TE, 1998, Am J Addict, 7, 156
Cited by
Relationship between sex hormones, reproductive stages and ADHD: A systematic review
Camara, B., Padoin, C., & Bolea, B. (2022) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01181-w · Cited by 35
Son, H. M., Calub, C. A., Fan, B., Dixon, J. F., Rezaei, S., Borden, J., Schweitzer, J. B., & Liu, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1394096 · Cited by 25
Baby, M., Priya, V., Pallavi, J., Karthik Chand, B., Srinivasan, L., Rana, S., Tawil, S., Haque, S., Ghosh, P., Bhattacharya, P., et al. (2025) · International Journal of Women's Health · doi:10.2147/ijwh.s511297 · Cited by 2
Metadata
- Authors
- Zalsman, G., & Shilton, T.
- Venue
- International Journal of Psychiatry in Clinical Practice
- Publisher
- Informa UK Limited
- Published
- 2016-04-02
- Volume
- 20
- Issue
- 2
- Pages
- 70-76
- ISSN
- 1365-1501
- 1471-1788
- Cited by
- 84
- References
- 52
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.